Island Pharmaceuticals Limited Appendix 4E Preliminary final report 1 1. Company details Name of entity: Island Pharmaceuticals Limited ABN: 48 641 183 842 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 2. Results for...
Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Island boosts Galidesivir supply as Ebola surges
- Date of AGM & Closing Date for Director Nominations
- Cleansing Notice
- Application for quotation of securities - ILA
- Investor presentation
Later from Island Pharmaceuticals
- Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
- Pivotal Marburg data secured for Galidesivir FDA pathway
- Annual General Meeting - Rescheduled Date
- Galidesivir GMP manufacturing commences
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals